Litcius/Paper detail

An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy

Wanqiong Li, Xueqin Zhu, Xiuman Zhou, Xiaoxi Wang, Wenjie Zhai, Bingyu Li, Jiangfeng Du, Guodong Li, Xinghua Sui, Yahong Wu, Mingxia Zhai, Yuanming Qi, Guanyu Chen, Yanfeng Gao

2021Journal of Controlled Release89 citationsDOI

Topics & Concepts

PharmacologyBioavailabilityCancer immunotherapyPeptideImmunotherapyChemistryCD8Monoclonal antibodyImmune systemDrug deliveryPeripheral blood mononuclear cellCancer researchMedicineAntibodyImmunologyIn vitroBiochemistryOrganic chemistryCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune Cell Function and Interaction
An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy | Litcius